Intermediates

Intermediates
Product Description

When you partner with DSM, you get access to our portfolio of high-quality lipids. We have a strong legacy of trust in the production and global commercialization of EPA and DHA derived from sustainable marine sources and microbial fermentation. This, backed by our capabilities to offer customized lipid ingredients and premixes based on your needs, global regulatory expertise and scientific and technical expertise, makes us the partner of choice for lipid intermediate solutions.

dsm-firmenich

  • CH
  • 2015
    On CPHI since
  • 1
    Certificates
  • 5000+
    Employees
Company types
Manufacturer/Innovator
Primary activities
API Producer

dsm-firmenich

  • CH
  • 2015
    On CPHI since
  • 1
    Certificates
  • 5000+
    Employees
Company types
Manufacturer/Innovator
Primary activities
API Producer

More Products from dsm-firmenich (4)

  • Functional ingredients

    Product Functional ingredients

    Bioavailability enhancers Our drug facilitators target and enhance bioavailability to help support the activity of your active ingredients. Antioxidants Our antioxidants can be used to improve the stability of your pharmaceutical formulation. In addition, due to their role in suppressing nitrosamine fo...
  • Active Pharmaceutical Ingredients (vitamins, cannabinoids, carotenoids)

    Product Active Pharmaceutical Ingredients (vitamins, cannabinoids, carotenoids)

    Vitamins When you partner with DSM, you get the broadest portfolio of proven, safe and innovative vitamin actives on the market. We are the first and only company in the world that can provide access to the US and Japanese Drug Master Files (DMFs) and the Certificates of Suitability (CEPs) for all 13 vita...
  • Cannabinoid actives / CBD APIs

    Product Cannabinoid actives / CBD APIs

    Our CBD API has 0% THC or other impurities in line with ICH guidelines and no pesticides, herbicides, or heavy metals. It has been tested by a World Anti-Doping Agency (WADA) lab, NSF and Informed Choice, confirmed for the absence of THC and banned substances. The product follows ICH Q7 regulations and is ...
  • Cannabinoid APIs (CBD)

    Product Cannabinoid APIs (CBD)

    The cannabinoid-based drug market is growing rapidly. To facilitate early-stage drug development in this emerging field of research, DSM has created an innovation platform, in partnership with Brains Bioceutical, to explore the full therapeutic potential of cannabinoid molecules, like cannabidiol (CBD).

dsm-firmenich resources (2)